David C Tabano1, Melissa L Anderson, Debra P Ritzwoller, Arne Beck, Nikki Carroll, Paul A Fishman, David C Grossman. 1. Kaiser Permanente Institute for Health Research, Denver, Colorado (Tabano, Drs Ritzwoller, Beck, Carroll); University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado (Tabano); Kaiser Permanente Washington Health Research Institute, Seattle, Washington (Drs Anderson, Fishman, Grossman); Department of Health Services University of Washington, Seattle, Washington (Drs Fishman, Grossman).
Abstract
OBJECTIVE: We assessed the relationship between diabetes mellitus (DM) and measures of worker productivity, direct health care costs, and costs associated with lost productivity (LP) among health care industry workers across two integrated health care systems. METHODS: We used data from the Value Based Benefit Design Health and Wellness Study Phase II (VBD), a prospective study of employees surveyed across health systems. Survey and health care utilization data were linked to estimate LP and health care utilization costs. RESULTS: Mean marginal lost productive time per week was 0.56 hours higher for respondents with DM. Mean adjusted monthly total health care utilization costs were $467 higher for respondents with DM. CONCLUSION: The impact of DM is reflected in higher rates of LP and higher indirect costs for employers related to LP and higher health care resource use.
OBJECTIVE: We assessed the relationship between diabetes mellitus (DM) and measures of worker productivity, direct health care costs, and costs associated with lost productivity (LP) among health care industry workers across two integrated health care systems. METHODS: We used data from the Value Based Benefit Design Health and Wellness Study Phase II (VBD), a prospective study of employees surveyed across health systems. Survey and health care utilization data were linked to estimate LP and health care utilization costs. RESULTS: Mean marginal lost productive time per week was 0.56 hours higher for respondents with DM. Mean adjusted monthly total health care utilization costs were $467 higher for respondents with DM. CONCLUSION: The impact of DM is reflected in higher rates of LP and higher indirect costs for employers related to LP and higher health care resource use.
Authors: Nora B Henrikson; Melissa L Anderson; Rebecca A Hubbard; Paul Fishman; David C Grossman Journal: Am J Prev Med Date: 2014-06-17 Impact factor: 5.043
Authors: Scott Ramsey; Kent H Summers; Stephanie A Leong; Howard G Birnbaum; Jason E Kemner; Paul Greenberg Journal: Diabetes Care Date: 2002-01 Impact factor: 19.112
Authors: Gregory A Nichols; Emily B Schroeder; Andrew J Karter; Edward W Gregg; Jay Desai; Jean M Lawrence; Patrick J O'Connor; Stanley Xu; Katherine M Newton; Marsha A Raebel; Ram D Pathak; Beth Waitzfelder; Jodi Segal; Jennifer Elston Lafata; Melissa G Butler; H Lester Kirchner; Abraham Thomas; John F Steiner Journal: Am J Epidemiol Date: 2014-12-16 Impact factor: 4.897
Authors: Gregory A Nichols; Jay Desai; Jennifer Elston Lafata; Jean M Lawrence; Patrick J O'Connor; Ram D Pathak; Marsha A Raebel; Robert J Reid; Joseph V Selby; Barbara G Silverman; John F Steiner; W F Stewart; Suma Vupputuri; Beth Waitzfelder Journal: Prev Chronic Dis Date: 2012-06-07 Impact factor: 2.830
Authors: L C Rosella; M Lebenbaum; T Fitzpatrick; D O'Reilly; J Wang; G L Booth; T A Stukel; W P Wodchis Journal: Diabet Med Date: 2015-08-19 Impact factor: 4.359
Authors: Kai Yeung; Weiwei Zhu; Susan M McCurry; Michael Von Korff; Robert Wellman; Charles M Morin; Michael V Vitiello Journal: J Am Geriatr Soc Date: 2021-10-11 Impact factor: 5.562